You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Untreated AML

Showing 1 - 25 of 4,263
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Baltimore (Decitabine, talazoparib)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
May 31, 2022

Leukemia, Acute Myeloid Leukemia, AML Trial in Tampa (Selinexor, Daunorubicin, Cytarabine)

Completed
  • Leukemia
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Sep 30, 2022

Acute Myeloid Leukemia (AML) Trial in Leipzig (VEN+AZA-5)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Leipzig, Germany
    Universitätsklinikum Leipzig, Klinik und Poliklinik für Hämatolo
Apr 25, 2023

Acute Myeloid Leukemia Trial in Lanzhou (Venetoclax, Azacitidine, Cladribine)

Recruiting
  • Acute Myeloid Leukemia
  • Lanzhou, Gansu, China
    Long Zhao
Apr 24, 2022

Acute Myeloid Leukemia Trial in United States (Tamibarotene, Venetoclax, Azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +7 more
Mar 27, 2022

Acute Myeloid Leukemia Trial in Aurora (Azacitidine and Venetoclax)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Azacitidine and Venetoclax
  • Aurora, Colorado
    University of Colorado Denver
Aug 1, 2022

Acute Myeloid Leukemia Trial in Houston (Azacitidine, Cladribine, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2022

Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 10, 2022

Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)

Recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 23, 2022

Leukemia, Myeloid, Acute Trial in New York (CPX-351)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • New York, New York
    Weill Cornell Medical College
Dec 10, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial in Worldwide (Glasdegib, Azacitidine)

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Salzburg, Austria
  • +17 more
Dec 14, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • +6 more
  • New Haven, Connecticut
  • +2 more
Sep 8, 2021

Acute Myelogenous Leukemia (AML) Due to Therapy, Acute Myeloid Leukemia With Myelodysplasia-Related Changes Trial in La Jolla,

Recruiting
  • Acute Myelogenous Leukemia (AML) Due to Therapy
  • Acute Myeloid Leukemia With Myelodysplasia-Related Changes
  • Orange, California
  • +2 more
Nov 30, 2022

Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies Trial

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • +3 more
  • Birmingham, Alabama
  • +26 more
Sep 12, 2022

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +15 more
  • trebananib
  • +3 more
  • Buffalo, New York
  • +1 more
Sep 8, 2022

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

Recruiting
  • Acute Biphenotypic Leukemia
  • +13 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

AML Trial in Puerto Rico, United States (Cytarabine (Phase 1 only), Lintuzumab-Ac225, Furosemide (Phase 1 only))

Completed
  • AML
  • Cytarabine (Phase 1 only)
  • +3 more
  • Los Angeles, California
  • +16 more
Feb 22, 2022

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Terminated
Has Results
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 28, 2022

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Terminated
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +15 more
  • fludarabine phosphate
  • +4 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 20, 2021

Acute Myeloid Leukemia, Adult Trial in Houston (ADI-PEG 20)

Recruiting
  • Acute Myeloid Leukemia, Adult
  • ADI-PEG 20
  • Houston, Texas
    MD Anderson Cancer Center
Sep 29, 2022

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (Azacitidine, Durvalumab)

Active, not recruiting
Has Results
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +94 more
Jun 9, 2022

Previously Untreated Acute Myeloid Leukemia Trial in United States (biological, other, drug)

Recruiting
  • Previously Untreated Acute Myeloid Leukemia
  • Samalizumab (BAML-16-001-S1)
  • +32 more
  • Phoenix, Arizona
  • +18 more
Oct 17, 2022

Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Tampa, Cleveland (Idarubicin, Cytarabine, Lenalidomide (Revlimid®))

Completed
Has Results
  • Myelodysplastic Syndrome
  • Acute Myeloid Leukemia
  • Tampa, Florida
  • +1 more
Dec 1, 2020

Acute Myeloid Leukemia (AML) Trial in United States (BP1001 in combination with Ventoclax plus decitabine, BP1001 plus

Recruiting
  • Acute Myeloid Leukemia (AML)
  • BP1001 in combination with Ventoclax plus decitabine
  • BP1001 plus decitabine
  • Fairway, Kansas
  • +5 more
Jan 3, 2022